Validation of Fetal Medicine Foundation competing‐risks model for small‐for‐gestational‐age neonate in early third trimester.

Objective: To evaluate the new 36‐week Fetal Medicine Foundation (FMF) competing‐risks model for the prediction of small‐for‐gestational age (SGA) at an earlier gestation of 30 + 0 to 34 + 0 weeks. Methods: This was a retrospective multicenter cohort study of prospectively collected data on 3012 women with a singleton pregnancy undergoing ultrasound examination at 30 + 0 to 34 + 0 weeks' gestation as part of a universal screening program. We used the default FMF competing‐risks model for prediction of SGA at 36 weeks' gestation combining maternal factors (age, obstetric and medical history, weight, height, smoking status, race, mode of conception), estimated fetal weight (EFW) and uterine artery pulsatility index (UtA‐PI) to calculate risks for different cut‐offs of birth‐weight percentile and gestational age at delivery. We examined the accuracy of the model by means of discrimination and calibration. Results: The prediction of SGA < 3rd percentile improved with the addition of UtA‐PI and with a shorter examination‐to‐delivery interval. For a 10% false‐positive rate, maternal factors, EFW and UtA‐PI predicted 88.0%, 74.4% and 72.8% of SGA < 3rd percentile delivered at < 37, < 40 and < 42 weeks' gestation, respectively. The respective values for SGA < 10th percentile were 86.1%, 69.3% and 66.2%. In terms of population stratification, if the biomarkers used are EFW and UtA‐PI and the aim is to detect 90% of SGA < 10th percentile, then 10.8% of the population should be scanned within 2 weeks after the initial assessment, an additional 7.2% (total screen‐positive rate (SPR), 18.0%) should be scanned within 2–4 weeks after the initial assessment and an additional 11.7% (total SPR, 29.7%) should be examined within 4–6 weeks after the initial assessment. The new model was well calibrated. Conclusions: The 36‐week FMF competing‐risks model for SGA is also applicable and accurate at 30 + 0 to 34 + 0 weeks and provides effective risk stratification, especially for cases leading to delivery < 37 weeks of gestation. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology. [ABSTRACT FROM AUTHOR]